A review of the effects of plasmapheresis on drug clearance

Pharmacotherapy

Volumn 17, Issue 4, 1997, Pages 684-695

  Kale Pradhan, Pramodini B ^a,c   Woo, Michael H ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMIODARONE; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BETA LACTAM ANTIBIOTIC; CARBAMAZEPINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; DIGITALIS; FRESH FROZEN PLASMA; HEPARIN; PROPRANOLOL; QUINIDINE; QUININE; SALICYLIC ACID; THEOPHYLLINE;

BLOOD SAMPLING; DRUG CLEARANCE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG OVERDOSE; DRUG WITHDRAWAL; HEMOPERFUSION; HUMAN; PLASMAPHERESIS; REVIEW;

HUMANS; METABOLIC CLEARANCE RATE; OVERDOSE; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PLASMAPHERESIS;

EID: 0030802577     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. MacPherson JL. Responding to the community's need for therapeutic hemapheresis. In: MacPherson JL, Kaprisin DO, eds. Therapeutic hemapheresis, vol. 1. Boca Raton, FL: CRC Press, 1985:3-11.
2. McKhann GM, Griffin JW, Cornblath DR, Mellits ED, Fischer RS, Quaskey SA. Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol 1988;23:347-53.
3. Dau PC, ed. Therapeutic plasma exchange disease compendium, 1st ed. Lakewood, CO: Cobe Laboratories, 1983:3-21.
4. Seyffart G. Plasmapheresis in treatment of acute intoxications. Trans Am Soc Artif Intern Organs 1981;28:673-6.
5. Sketris IS, Parker WA, Jones JV. Plasmapheresis: its effect on toxic agents and drugs. Plasma Ther Transfus Technol 1984;5:305-17.
6. Gibson TP. Kinetics of drug removal. Trans Am Soc Artif Intern Organs 1982;28:672-3.
7. Gilcher RO. Apheresis: principles and practice. In: Rossi EC, Simon TL, Moss GS, Gould SA, eds. Principles of transfusion medicine. Philadelphia: Williams & Wilkins, 1996:537-46.
8. Schwab PJ, Fahey JL. Treatment of Waldenstöm's macroglobulinemia by plasmapheresis. N Engl J Med 1960;236:574-9.
9. Cohen S, Freeman T. Metabolic heterogeneity of human g-globulin. Biochem J 1960;76:475-87.
10. Rosenfield RE, Jagathambal Transfusion therapy for autoimmune hemolytic anemia. Semin Hematol 1976;13:311-21.
11. Slocombe GW, Newland AC, Colvin MP, Colvin BT. The role of intensive plasma exchange in the prevention and management of haemorrhage in patients with inhibitors to factor VIII. Br J Haematol 1981;47:577-85.
12. Lau P, Sholtis CM, Aster RH. Post-transfusion purpura: an enigma of alloimmunization. Am J Hematol 1980;9:331-6.
13. Messner HA, Fauser AA, Curtis JE, Dotten D. Control of antibody-mediated pure red cell aplasia by plasmapheresis. N Engl J Med 1981;304:1334-8.
14. Dau PC, Lindstrom JM, Cassel CK, Denys EH, Shev EE, Spitler LE. Plamapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med 1977;297:1134-40.
15. Newsom-Davis J, Pinching AJ, Vincent A, Wilson SG. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurolog 1978;28:266-72.
16. Dau PC. Response to plasmapheresis and immunosuppressive drug therapy in sixty myasthenia gravis patients. Ann NY Acad Sci 1981;377:700-8.
17. Gibberd FB, Billimoria JD, Page NGR, Retsas S. Heredopathia atactica polyneuritiformis (Refsum's disease) treated by diet and plasma-exchange. Lancet 1979;1:575-8.
18. Lockwood CM, Ress AJ, Pearson TA, Evans DJ, Peters DK, Wilson CB. Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet 1976;1:711-15.
19. Johnson JP, Whitman W, Briggs WA, Wilson CB. Plasmapheresis and immunosuppressive agents in antibasement membrane antibody-induced Goodpasture's syndrome. Am J Med 1978;64:354-9.
20. Simpson IJ, Doak PB, Williams LC, et al. Plasma exchange in Goodpasture's syndrome. Am J Nephrol 1982;2:301-11.
21. Peters DK, Rees AJ, Lockwood CM, Pusey CD. Treatment and prognosis in antibasement membrance antibody-mediated nephritis. Transplant Proc 1982;14:513-21.
22. Robinson EAE, Tovey LAD. Intensive plasma exchange in the management of severe Rh disease. Br J Haematol 1980;45:621-31.
23. Rock G, Lafreniere I, Chan L, McCombie N. Plasma exchange in the treatment of hemolytic disease of the newborn. Transfusion 1981;21:546-51.
24. Bowman JM, Peddle LJ, Anderson C. Plasmapheresis in severe Rh iso-immunization. Vox Sang 1968;15:272-7.
25. Powell LC Jr. Intense plasmapheresis in the pregnant Rh-sensitized woman. Am J Obstet Gynecol 1968;101:153-70.
26. Clarke CA, Elson CJ, Bradley J, Donohoe WTA, Lehane D, Hughes-Jones NC. Intensive plasmapheresis as a therapeutic measure in Rhesus-immunized women. Lancet 1970;1:793-8.
27. Byrnes JJ, Khurana M. Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 1977;297:1386-9.
28. Bukowski RM, King JW, Hewlett JS. Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood 1977;50:413-17.
29. Myers TJ, Wakken CJ, Ball ED, Tremont SJ. Thrombotic thrombocytopenic purpura: combined treatment with plasmapheresis and antiplatelet agents. Ann Intern Med 1980;92:149-55.
30. Taft EG. Thrombotic thrombocytopenic purpura and dose of plasma exchange. Blood 1979;54:842-9.
31. Byrnes JJ, Lian ECY. Recent therapeutic advances in thrombotic thrombocytopenic purpura. Semin Thromb Haemost 1979;5:199-215.
32. Cuttner J. Thrombotic thrombocytopenic purpura: a ten-year experience. Blood 1980;56:302-6.
33. Branda RF, Tate DY, McCullough JJ, Jacob HS. Plasma exchange in the treatment of fulminant idiopathic (autoimmune) thrombocytopenic purpura. Lancet 1978;1:688-90.
34. Marder VJ, Nusbacher J, Anderson FW. One-year follow-up of plasma exchange therapy in 14 patients with idiopathic thrombocytopenic purpura. Transfusion 1981;21:291-8.
35. Berkman EM, Orlin JB. Use of plasmapheresis and partial plasma exchange in the management of patients with cryoglobulinemia. Transfusion 1980;20:171-8.
36. McLeod BC, Sassetti RJ. Plasmapheresis with return of cryoglobulin-depleted autologous plasma (cryoglobulinpheresis) in cryoglobulinemia. Blood 1980;55:866-70.
37. Bombardieri S, Maggiore Q, L'Abbate A, Bartolomeo F, Ferri C. Plasma exchange in essential mixed cryoglobulinemia. Plasma Ther Transfus Technol 1981;2:101-9.
38. Rock GA, Blanchette VS, McKendry RJ, Kardish R. Plasmapheresis and cryoglobulinemia: an evaluation of cold precipitation as a method of removing abnormal protein [abstr]. Blood 1982;60(suppl 1):181A.
39. Thompson GR, Lowenthal R, Myant NB. Plasma exchange in the management of homozygous familial hypercholesterolaemia. Lancet 1975;1:1208-11.
40. King MEE, Breslow JL, Lees RS. Plasma-exchange therapy of homozygous familial hypercholesterolemia. N Engl J Med 1980;302:1457-9.
41. Thompson GR. Plasma exchange for hypercholesterolemia. Lancet 1981;1:1246-8.
42. Valbonesi M, Garelli S, Mosconi L, Zerbi D, Celano I. Plasma exchange as a therapy for Guillain-Barré syndrome with immune complexes. Vox Sang 1981;41:74-8.
43. Maas AIR, Busch HFM, van der Heul C. Plasma infusion and plasma exchange in chronic idiopathic polyneuropathy. N Engl J Med 1981;305:344.
44. Server AC, Lefkowith J, Braine H, McKhann GM. Treatment of chronic relapsing inflammatory polyradicuolneuropathy by plasma exchange. Ann Neurol 1979;6:258-61.
45. Latov N, Sherman WH, Nemni R, et al. Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin. N Engl J Med 1980;303:618-21.
46. Dau PC, Petajan JH, Johnson KP, Panitch HS, Bornstein MB. Plasmapheresis in multiple sclerosis: preliminary findings. Neurology 1980;30:1023-8.
47. Weiner HL, Dawson DM. Plasmapheresis in multiple sclerosis: preliminary study. Neurology 1980;30:1029-33.
48. Tindall RSA, Walker JE, Ehle AL, Near L, Rollins J, Becker D. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone. Neurology 1982;32:739-43.
49. Stefoski D, Schauf CL, McCleod BC, Haywood CP, Davis FA. Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosis. Neurology 1982;32:904-7.
50. Hauser SL, Dawson DM, Lehrich JR, et al. Intensive immunosuppression in progressive multiple sclerosis: a randomized three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med 1983;308:173-80.
51. Dwosh IL, Giles AR, Ford PM, et al. Plasmapheresis therapy in rheumatoid arthritis: a controlled, double-blind and crossover trial. N Engl J Med 1983;20:1124-9.
52. Wallace D, Goldfinger D, Lowe C, et al. A double-blind, controlled study of lymphoplasmapheresis versus sham apheresis in rheumatoid arthritis. N Engl J Med 1982;306:1406-10.
53. Rothwell RS, Davis P, Gordon PA, et al. A controlled study of plasma exchange in the treatment of severe rheumatoid arthritis. Arthritis Rheum 1980;23:785-90.
54. Verrier Jones J, Cumming RH, Bucknall RC, et al. Plasmapheresis in the management of acute systemic lupus erythematosus? Lancet 1976;1:709-11.
55. Verrier Jones J, Cumming RH, Bacon PA, et al. Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus. Q J Med 1979;48:555-76.
56. Parry HF, Moran CJ, Snaith ML, et al. Plasma exchange in systemic lupus erythematosus. Ann Rheum Dis 1981;40:224-8.
57. Wei N, Klippel JH, Huston DP, et al. Randomized trial of plasma exchange in mild systemic lupus erythematosus. Lancet 1983;1:17-22.
58. Gipstein RM, Adams DA, Grabie MT, Peter JB. Response of lupus nephritis to plasmapheresis without demonstration of circulating immune complexes. Am J Med Sci 1982;284:37-41.
59. Blum SP, Lessig MA. Plasmapheresis in quinidine purpura. Plasma Ther Transfus Technol 1980;1(4):65.
60. Russel DC, Paton L, Douglas AC. Amiodarone associated alveolitis and polyarthropathy: treatment by plasma exchange. Br Heart J 1983;50:491-4.
61. Manzano L, Yebra M, Vargas JA, et al. Plasmapheresis in heparin-induced thrombocytopenia and thrombosis. Stroke 1990;21(8):1236.
62. Brady J, Riccio JA, Yumen MH, et al. Plasmapheresis: a therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis. Am J Clin Pharm 1991;96(3):394-7.
63. Vender JS, Matthew EB, Silverman JM, et al. Heparin-associated thrombocytopenia: alternative managements. Anesth Analg 1986;65:520-2.
64. Munoz SJ, Martinez-Hernandez A, Maddry WC. Intrahepatic cholestasis and phospholipidosis associated with the use of trimethoprim-sulfamethoxazole. Hepatology 1990;12(2):342-7.
65. Baumbauer R, Jutzler GA, Stolz D, Doenecke P. Detoxification using a technically simplified plasma filtration system. In: Nose Y, Malchesky PS, Smith JW, Krakauer RS, eds. Plasmapheresis: therapeutic applications and new techniques. New York: Raven Press, 1983:241-50.
66. Sabto J, Pierce RM, West RH, Gurr FW. Hemodialysis, peritoneal dialysis, plasmapheresis, and forced diuresis for the treatment of quinine overdose. Clin Nephrol 1981;16:264-8.
67. Kale P, Thomson PA, Provenzano R, Higgins MJ. Evaluation of plasmapheresis in the treatment of an acute overdose of carbamazepine. Ann Pharmacother 1993;27:866-70.
68. Setna M, Solomon G, Cedarbaum J, Kutt H. Successful treatment of massive carbamazepine overdose. Epilepsia 1989;30:71-3.
69. Laussen P, Shann F, Butt W, Tibballs J. Use of plasmapheresis in acute theophylline toxicity. Crit Care Med 1991;19(2):288-90.
70. Rabetoy GM, Price CA, Findlay JWA, Sailstad JM. Treatment of digoxin intoxication in a renal failure patient with digoxin-specific antibody fragments and plasmapheresis. Am J Nephrol 1990;10:518-21.
71. Pierga JV, Beuzeboc P, Dorval T, Palangie T, Pouillart P. Favourable outcome after plasmapheresis for vincristine overdose. Lancet 1992;340:185.
72. Chu G, Mantin R, Shen YM, et al. Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management. Cancer 1993;72(12):3707-14.
73. Stigelman WH Jr, Henry DH, Talbert RL, Townshend RJ. Prednisone and prednisolone removal by plasma exchange. Clin Pharm 1984;3:402-7.
74. Keller F, Jauff A, Schultze G, et al. Effect of repeated plasma exchange on steady-state kinetics of digoxin and digitoxin. Arzneim Forsch Drug Res 1984;34:83-6.
75. White RL, Garnett WR, Poynor WJ, Allen JH, Sharp DE. Salicylate removal during plasma exchange in normal volunteers. Clin Pharm 1984;3:396-402.
76. Talbert RL, Wong YY, Duncan DB. Propranolol plasma concentrations and plasmapheresis. Drug Intell Clin Pharm 1981;15:993-6.
77. Chan GL, Hodge EE. Effect of plasmapheresis on cyclosporine pharmacokinetics. Ann Pharmacother 1991;25:211.
78. Bakken JS, Cavalieri SJ, Gangeness D, Kubat T, Pollack JR. Influence of therapeutic plasmapheresis on elimination of ceftriaxone. Antimicrob Agents Chemother 1993;37(5):1171-3.
79. Bakken JS, Cavalieri SJ, Gangeness D. Influence of plasma exchange pheresis on plasma elimination of ceftriaxone. Antimicrob Agents Chemother 1990;34(6):1276-7.
80. Bozhurt F, Scholimeyer P, Keller E. Kinetics of ceftazidime during plasmapheresis. Eur J Clin Pharmacol 1987;33:197-201.
81. Applegate R, Schwartz D, Bennett WM. Removal of tobramycin during plasma exchange therapy. Ann Intern Med 1981;94:820-1.
82. Ouellette SM, Visconti JA, Kennedy MS. A pharmacokinetic evaluation of the effect of plasma exchange on tobramycin disposition. Clin Exp Dialysis Apheresis 1983;7:225-33.
83. Kale-Pradhan PB, Dehoorne-Smith ML, Jaworski DA, Hare BL, Provenzano R, Higgins MJ. Evaluation of plasmapheresis on the removal of tobramycin. Pharmacotherapy 1995;15:673-6.
84. Lai CW, Leppik IE, Jenkins DC, Sood P. Epilepsy, myasthenia gravis, and effect of plasmapheresis on antiepileptic drug concentrations. Arch Neurol 1990;47:66-8.
85. Liu E, Rubenstein M. Phenytoin removal by plasmapheresis in thrombotic thrombocytopenic purpura. Clin Pharmacol Ther 1982;31:762-5.
86. Tobias JD, Baker DK, Hurwitz CA. Removal of phenytoin by plasmapheresis in a patient with thrombotic thrombocytopenic purpura. Clin Pediatr 1992;31(2):105-8.
87. Nasca TJ, Huff N, Livengood BH. Phenytoin pharmacokinetics in therapeutic plasmapheresis. J Clin Pharmacol 1985;25:302-4.
88. Brown-Molnar CS, Bauer LA, Horn JR. Phenytoin removal by plasmapheresis in renal insufficiency. Am J Nephrol 1986;6:302-6.
89. Lunde PKM, Rane A, Yaffe SF, et al. Plasma protein binding of diphenylhydantoin in man. Clin Pharmacol Ther 1970;11:846-55.
90. Porter RJ, Layzer RB. Plasma albumin concentration and diphenylhydantoin binding in man. Arch Neurol 1975; 32:298-303.